A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy

Clinical trial NCT02987114. Status: COMPLETED. Sponsor: PhytoTech Therapeutics, Ltd.